1-3 of 3
Authors: Roberto De Luca
Sort by
Journal Article
EXTH-16. UNBIASED DISCOVERY OF SYNERGISTIC VULNERABILITIES AGAINST GLIOBLASTOMA: AN INNOVATIVEIN VIVO CRISPR PROFILING PLATFORM TO UNLEASH THE POWER OF TUMOR-TARGETED CYTOKINE THERAPY Free
Irma Sakic and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii239–viii240, https://doi.org/10.1093/neuonc/noae165.0947
Published: 11 November 2024
Journal Article
CTIM-22. THE COMBINATION OF LOMUSTINE AND THE IMMUNOCYTOKINE L19TNF IS A PROMISING TREATMENT FOR RECURRENT GLIOBLASTOMA Free
Thomas Look and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii64–vii65, https://doi.org/10.1093/neuonc/noac209.254
Published: 14 November 2022
Journal Article
DDRE-21. LOMUSTINE AND TARGETED-CYTOKINE THERAPY: A BENEFICIAL LIAISON FOR RECURRENT GLIOBLASTOMA Free
Tobias Weiss and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi78–vi79, https://doi.org/10.1093/neuonc/noab196.305
Published: 12 November 2021
Advertisement
Advertisement